Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Minet, I. Vivodtzev, R. Tamisier, F. Arbib, B. Wuyam, J. F. Timsit, D. Monneret, J. C. Borel, J. P. Baguet, P. Levy, J. L. Pepin (Grenoble Cedex 09, La Tronche, France). Reduced six-minute walking distance is associated with endothelial dysfunction in COPD patients. Eur Respir J 2011; 38: Suppl. 55, 1225

Member's Comments

No comment yet.

Related content which might interest you: Dysfunction of respiratory muscles contribute to 6-minute walk distance limitation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 63s Year: 2006 Impact of pulmonary rehabilitation on six-minute walk distance in patients with very severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010 The 6-min walking distance: long-term follow up in patients with COPD Source: Eur Respir J 2007; 29: 535-540 Year: 2007 Pulmonary function and six-minute walking distance in chronic renal failure patients on haemodialysis Source: Eur Respir J 2002; 20: Suppl. 38, 183s Year: 2002 Predictors for longitudinal change in 6-minute walk distance in COPD patients Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation Year: 2012 Influence of muscle mass and function and healthy status on six-minute walk distance in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 721s Year: 2005 Relationship between six-minute walk test and resting lung function in patients with IPF Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003 The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004 Association of 6-minute walk distance and maximal work capacity assessed by ergometry in patients with obstructive and restrictive lung diseases Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 16s Year: 2005 Evaluating impairment in exercise capacity in COPD patients with the six-minute walk distance test: a comparative study Source: Eur Respir J 2006; 28: Suppl. 50, 767s Year: 2006 Predictors of six-minute walk distance at baseline and after three years in COPD patients Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011 Improvement of 6-minutes walking test (6MWT) and pulmonary functional status after an inpatient pulmonary rehabilitation program (PRP) in moderate-severe and severe COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 244s Year: 2004 Six-minute walked distance in COPD patients with chronic respiratory insufficiency Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006 Relationships between changes in the respiratory distress level of COPD patients undergoing a six-minute walking distance test, their physical functions, and exercise capacity Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Six-min walk distance test better reflects maximal exercise tolerance in severe, but not in mild COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 356s Year: 2001 Variables associated to desaturation during the six-minute walking test in interstitial lung disease Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Hyperinflation and health status contribute to 6-minute walk distance in COPD, contrary to airway inflammation Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 Correlation between cardiorespiratory coupling and six-minute walking tests in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – COPD phenotypes Year: 2020